Matches in SemOpenAlex for { <https://semopenalex.org/work/W2048274329> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W2048274329 endingPage "83" @default.
- W2048274329 startingPage "80" @default.
- W2048274329 abstract "The discovery of heparin and its eventual incorporation into many therapeutic and diagnostic procedures has made this agent ubiquitous in the fields of cardiac and vascular medicine. Heparin however does have a significant complication and side-effect profile that includes both bleeding as well as vessel thrombosis through the development of heparin-induced thrombocytopenia. The recent addition of direct thrombin inhibitors, for example, bivalirudin, to the anticoagulation armaterium has produced favorable outcomes. Most of the experience with bivalirudin has been in coronary interventions and only recently have more interventionalists been turning to this agent as the sole anticoagulant for peripheral interventions even in patients who could tolerate heparin. In this review, we describe our experience with bivalirudin in peripheral interventions emphasizing how we dose and monitor this drug. In addition, this article discusses the findings in existing clinical trials involving bivalirudin. The discovery of heparin and its eventual incorporation into many therapeutic and diagnostic procedures has made this agent ubiquitous in the fields of cardiac and vascular medicine. Heparin however does have a significant complication and side-effect profile that includes both bleeding as well as vessel thrombosis through the development of heparin-induced thrombocytopenia. The recent addition of direct thrombin inhibitors, for example, bivalirudin, to the anticoagulation armaterium has produced favorable outcomes. Most of the experience with bivalirudin has been in coronary interventions and only recently have more interventionalists been turning to this agent as the sole anticoagulant for peripheral interventions even in patients who could tolerate heparin. In this review, we describe our experience with bivalirudin in peripheral interventions emphasizing how we dose and monitor this drug. In addition, this article discusses the findings in existing clinical trials involving bivalirudin." @default.
- W2048274329 created "2016-06-24" @default.
- W2048274329 creator A5043666413 @default.
- W2048274329 creator A5072826659 @default.
- W2048274329 creator A5077958792 @default.
- W2048274329 date "2006-06-01" @default.
- W2048274329 modified "2023-09-26" @default.
- W2048274329 title "Bivalirudin in Peripheral Interventions" @default.
- W2048274329 cites W2003683425 @default.
- W2048274329 cites W2011130615 @default.
- W2048274329 cites W2056958055 @default.
- W2048274329 cites W2082333685 @default.
- W2048274329 cites W2102296549 @default.
- W2048274329 cites W2102695511 @default.
- W2048274329 cites W2121251309 @default.
- W2048274329 cites W2130652855 @default.
- W2048274329 cites W2165710426 @default.
- W2048274329 doi "https://doi.org/10.1053/j.tvir.2006.12.007" @default.
- W2048274329 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17482105" @default.
- W2048274329 hasPublicationYear "2006" @default.
- W2048274329 type Work @default.
- W2048274329 sameAs 2048274329 @default.
- W2048274329 citedByCount "4" @default.
- W2048274329 countsByYear W20482743292012 @default.
- W2048274329 countsByYear W20482743292020 @default.
- W2048274329 crossrefType "journal-article" @default.
- W2048274329 hasAuthorship W2048274329A5043666413 @default.
- W2048274329 hasAuthorship W2048274329A5072826659 @default.
- W2048274329 hasAuthorship W2048274329A5077958792 @default.
- W2048274329 hasConcept C118552586 @default.
- W2048274329 hasConcept C126322002 @default.
- W2048274329 hasConcept C141071460 @default.
- W2048274329 hasConcept C164705383 @default.
- W2048274329 hasConcept C177713679 @default.
- W2048274329 hasConcept C27415008 @default.
- W2048274329 hasConcept C2776472838 @default.
- W2048274329 hasConcept C2777292125 @default.
- W2048274329 hasConcept C2777557582 @default.
- W2048274329 hasConcept C2777565915 @default.
- W2048274329 hasConcept C2778205648 @default.
- W2048274329 hasConcept C2780400711 @default.
- W2048274329 hasConcept C2780868729 @default.
- W2048274329 hasConcept C500558357 @default.
- W2048274329 hasConcept C57002609 @default.
- W2048274329 hasConcept C71924100 @default.
- W2048274329 hasConcept C89560881 @default.
- W2048274329 hasConceptScore W2048274329C118552586 @default.
- W2048274329 hasConceptScore W2048274329C126322002 @default.
- W2048274329 hasConceptScore W2048274329C141071460 @default.
- W2048274329 hasConceptScore W2048274329C164705383 @default.
- W2048274329 hasConceptScore W2048274329C177713679 @default.
- W2048274329 hasConceptScore W2048274329C27415008 @default.
- W2048274329 hasConceptScore W2048274329C2776472838 @default.
- W2048274329 hasConceptScore W2048274329C2777292125 @default.
- W2048274329 hasConceptScore W2048274329C2777557582 @default.
- W2048274329 hasConceptScore W2048274329C2777565915 @default.
- W2048274329 hasConceptScore W2048274329C2778205648 @default.
- W2048274329 hasConceptScore W2048274329C2780400711 @default.
- W2048274329 hasConceptScore W2048274329C2780868729 @default.
- W2048274329 hasConceptScore W2048274329C500558357 @default.
- W2048274329 hasConceptScore W2048274329C57002609 @default.
- W2048274329 hasConceptScore W2048274329C71924100 @default.
- W2048274329 hasConceptScore W2048274329C89560881 @default.
- W2048274329 hasIssue "2" @default.
- W2048274329 hasLocation W20482743291 @default.
- W2048274329 hasLocation W20482743292 @default.
- W2048274329 hasOpenAccess W2048274329 @default.
- W2048274329 hasPrimaryLocation W20482743291 @default.
- W2048274329 hasRelatedWork W1613605883 @default.
- W2048274329 hasRelatedWork W162394755 @default.
- W2048274329 hasRelatedWork W2002638971 @default.
- W2048274329 hasRelatedWork W2013018670 @default.
- W2048274329 hasRelatedWork W2065797774 @default.
- W2048274329 hasRelatedWork W2070199458 @default.
- W2048274329 hasRelatedWork W2098251454 @default.
- W2048274329 hasRelatedWork W2115993405 @default.
- W2048274329 hasRelatedWork W3006441576 @default.
- W2048274329 hasRelatedWork W4256164684 @default.
- W2048274329 hasVolume "9" @default.
- W2048274329 isParatext "false" @default.
- W2048274329 isRetracted "false" @default.
- W2048274329 magId "2048274329" @default.
- W2048274329 workType "article" @default.